Literature DB >> 8568593

Grading of precancerous laryngeal lesions by multiparameter image analysis at separate epithelial layers.

T Dreyer1, C Popella, B Hinrichs, R M Bohle, U Pohlmann, A Schulz, H Glanz.   

Abstract

In order to detect early precancerous changes which do not involve the whole thickness of the epithelium, we used a novel image analysing program based on an IBAS system (Kontron, Germany) to determine nuclear DNA content (NC) as well as average nuclear area (NA) and variation of nuclear area (VA), in the entire epithelium and in three sublayers, parabasal, intermediate, and superficial. DNA aneuploidy was found in only half of the cases classified as 'high-grade' (HG) lesions, comprising carcinoma in situ (CIS) and severe epithelial dysplasias (EDIII), and was chiefly demonstrable in the parabasal third of the epithelium. The other lesions were DNA euploid. HG lesions showed highly significant increases of NA and VA at the lower levels of the epithelium when compared with 'low-grade' (LG) lesions comprising moderate and mild epithelial dysplasias (EDII and EDI). Our data show that the combination of multiparameter image analysis with conventional morphology assists in the objective grading of precancerous lesions and permits the reliable detection of high-grade lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8568593     DOI: 10.1002/path.1711770409

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  2 in total

1.  Indirect autofluorescence laryngoscopy in the diagnosis of laryngeal cancer and its precursor lesions.

Authors:  C Arens; T Dreyer; H Glanz; K Malzahn
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-07-17       Impact factor: 2.503

2.  Histologic assessment of epithelial thickness in early laryngeal cancer or precursor lesions and its impact on endoscopic imaging.

Authors:  Christoph Arens; Hiltrud Glanz; Joachim Wönckhaus; Karin Hersemeyer; Marcel Kraft
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-09       Impact factor: 3.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.